Atlas Trials

Lung Cancer Group Cologne

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lung Cancer Group Cologne

RecordFirmDate
FGFR Inhibitor in FGFR Dysregulated Cancer (NCT03827850)Lung Cancer Group Cologne2019-03-25

Track Lung Cancer Group Cologne automatically

Every clearance here is in the API, with alerts when new ones post.